View in EDS

Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers.

Saved in:
Bibliographic Details
Title: Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers.
Authors: Davis J; Research Clinical Pharmacology, Pfizer Inc, Sandwich, Kent, United Kingdom. john.davis@pfizer.com, Hackman F, Ndongo MN, Choo H, Lewis D, Tawadrous M, Goodrich J, Langdon G
Source: Clinical therapeutics [Clin Ther] 2010 Oct; Vol. 32 (11), pp. 1889-95.
Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 21095483
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Davis+J%22">Davis J</searchLink>; Research Clinical Pharmacology, Pfizer Inc, Sandwich, Kent, United Kingdom. john.davis@pfizer.com<br /><searchLink fieldCode="AU" term="%22Hackman+F%22">Hackman F</searchLink><br /><searchLink fieldCode="AU" term="%22Ndongo+MN%22">Ndongo MN</searchLink><br /><searchLink fieldCode="AU" term="%22Choo+H%22">Choo H</searchLink><br /><searchLink fieldCode="AU" term="%22Lewis+D%22">Lewis D</searchLink><br /><searchLink fieldCode="AU" term="%22Tawadrous+M%22">Tawadrous M</searchLink><br /><searchLink fieldCode="AU" term="%22Goodrich+J%22">Goodrich J</searchLink><br /><searchLink fieldCode="AU" term="%22Langdon+G%22">Langdon G</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227706726%22">Clinical therapeutics</searchLink> [Clin Ther] 2010 Oct; Vol. 32 (11), pp. 1889-95.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Excerpta+Medica%22">Excerpta Medica </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7706726 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-114X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201492918%22">01492918 </searchLink><i>NLM ISO Abbreviation: </i>Clin Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21095483
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clinthera.2010.10.007
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1889
    Titles:
      – TitleFull: Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Davis J
      – PersonEntity:
          Name:
            NameFull: Hackman F
      – PersonEntity:
          Name:
            NameFull: Ndongo MN
      – PersonEntity:
          Name:
            NameFull: Choo H
      – PersonEntity:
          Name:
            NameFull: Lewis D
      – PersonEntity:
          Name:
            NameFull: Tawadrous M
      – PersonEntity:
          Name:
            NameFull: Goodrich J
      – PersonEntity:
          Name:
            NameFull: Langdon G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2010 Oct
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1879-114X
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Clinical therapeutics
              Type: main
ResultId 1